retatrutide clinical trial results obesity Lilly's triple agonist achieves 16.8% weight loss in phase 3 obesity #pharma #retatrutide #biotech #healthcareinnovation
Pay in 4 interest-free payments of $6.92 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Oct 2 - Oct 7



























